Neuroendocrine Carcinoma, Grade 3

Also known as: Grade III Neuroendocrine Carcinoma / Neuroendocrine carcinoma, grade 3 (morphologic abnormality)

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB11945	Avelumab	2	Completed	1
DB01590	Everolimus	2	Completed	1
DB09035	Nivolumab	2	Active Not Recruiting	1
DB00853	Temozolomide	2	Active Not Recruiting	1